N

Nang Kuang Pharmaceutical Co Ltd
TWSE:1752

Watchlist Manager
Nang Kuang Pharmaceutical Co Ltd
TWSE:1752
Watchlist
Price: 36.5 TWD 0.27% Market Closed
Market Cap: NT$3.7B

Net Margin

11.6%
Current
Declining
by 2%
vs 3-y average of 13.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
11.6%
=
Net Income
NT$257m
/
Revenue
NT$2.2B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
11.6%
=
Net Income
NT$257m
/
Revenue
NT$2.2B

Peer Comparison

Country Company Market Cap Net
Margin
TW
Nang Kuang Pharmaceutical Co Ltd
TWSE:1752
3.7B TWD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1.1T USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
564.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
287.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
294.9B USD
Loading...
CH
Novartis AG
SIX:NOVN
229.6B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
215B GBP
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
Loading...
US
Pfizer Inc
NYSE:PFE
153.2B USD
Loading...
FR
Sanofi SA
PAR:SAN
98.9B EUR
Loading...

Market Distribution

Higher than 71% of companies in Taiwan
Percentile
71st
Based on 1 075 companies
71st percentile
11.6%
Low
-22 082.4% — 1%
Typical Range
1% — 11.1%
High
11.1% — 1 580%
Distribution Statistics
Taiwan
Min -22 082.4%
30th Percentile 1%
Median 5.3%
70th Percentile 11.1%
Max 1 580%

Nang Kuang Pharmaceutical Co Ltd
Glance View

Market Cap
3.7B TWD
Industry
Pharmaceuticals

Nang Kuang Pharmaceutical Co., Ltd. engages in the manufacture, process, and sale of western medicine and medical equipment. The company is headquartered in Tainan, Tainan. The company went IPO on 2005-06-10. The firm main products include injections, sterile injections, powder injections, hard capsules, bare ingots, film ingots, casing ingots, granules and creams, among others. The firm is also engaged in the manufacture, processing and trading of medical equipment. The firm distributes its products within the domestic market and to overseas markets.

Intrinsic Value
42.37 TWD
Undervaluation 14%
Intrinsic Value
Price
N
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
11.6%
=
Net Income
NT$257m
/
Revenue
NT$2.2B
What is Nang Kuang Pharmaceutical Co Ltd's current Net Margin?

The current Net Margin for Nang Kuang Pharmaceutical Co Ltd is 11.6%, which is below its 3-year median of 13.6%.

How has Net Margin changed over time?

Over the last 3 years, Nang Kuang Pharmaceutical Co Ltd’s Net Margin has decreased from 13.5% to 11.6%. During this period, it reached a low of 10% on Sep 30, 2024 and a high of 19.3% on Jun 30, 2023.

Back to Top